NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 174 filers reported holding NEVRO CORP in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $15,395,000 | -12.2% | 192,800 | -4.7% | 0.02% | -15.0% |
| Q1 2018 | $17,543,000 | +51.8% | 202,410 | +20.9% | 0.02% | +53.8% |
| Q4 2017 | $11,558,000 | -44.5% | 167,410 | -26.9% | 0.01% | -50.0% |
| Q3 2017 | $20,811,000 | +21.8% | 228,990 | -0.2% | 0.03% | +18.2% |
| Q2 2017 | $17,081,000 | -5.8% | 229,490 | +18.6% | 0.02% | -4.3% |
| Q1 2017 | $18,130,000 | +28.0% | 193,490 | -0.8% | 0.02% | +21.1% |
| Q4 2016 | $14,168,000 | -52.3% | 194,990 | -31.5% | 0.02% | -52.5% |
| Q3 2016 | $29,702,000 | +52.2% | 284,530 | +7.6% | 0.04% | +48.1% |
| Q2 2016 | $19,509,000 | +58.8% | 264,490 | +21.1% | 0.03% | +58.8% |
| Q1 2016 | $12,288,000 | – | 218,410 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
| Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
| Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
| Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
| Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
| Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
| Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
| ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
| PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |